Eris Lifesciences Limited (ERIS)

Volume: 1,413Avg Vol 1W: 14,376Avg Vol 1M: 38,32452W Range:₹1,200₹1,910

NSE BSE

₹1,411.1▲ 2.51%

Key Ratios

Updated just now

Market Cap₹19,440 Cr

Current Price₹1,411.1

Previous Close₹1,376.5

High / Low (52w)₹1,910 / ₹1,200

Volume1,413

Avg Vol (1W)14,376

Avg Vol (1M)38,324

Stock P/E54.84

Book Value₹281.78

Dividend Yield0.51%

ROE15.87%

ROA8.79%

Revenue (TTM)—

Revenue Growth44.02%

Profit Margin19.89%

Total Debt₹1,738 Cr

Shares Outstanding14 Cr

Face Value₹1

EPS (TTM)₹20.6

P/B4.88

Debt / Equity0.6

50 DMA₹1,370.04

200 DMA₹1,369.1

Day change+2.51%

Price Chart

₹1,411.1▼ 11.82% · 1Y

2025-10-20

2026-06-16

20-day avg volume: 40K shares

Pros

Healthy return on equity of 15.9%.
Company is almost debt-free.
Revenue grew 43% YoY.

Cons

Stock trades at a high P/E of 55.

Quarterly Results

Metric	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024	Jun 2024	Mar 2024	Dec 2023	Sept 2023	Jun 2023	Mar 2023	Dec 2022	Sept 2022	Jun 2022	Mar 2022	Dec 2021	Sept 2021	Jun 2021	Mar 2021	Dec 2020	Sept 2020	Jun 2020	Mar 2020
Revenue	₹757 Cr	₹807 Cr	₹792 Cr	₹773 Cr	₹705 Cr	₹727 Cr	₹741 Cr	₹720 Cr	₹551 Cr	₹486 Cr	₹505 Cr	₹467 Cr	₹403 Cr	₹423 Cr	₹461 Cr	₹399 Cr	₹306 Cr	₹332 Cr	₹360 Cr	₹349 Cr	₹278 Cr	₹310 Cr	₹330 Cr	₹293 Cr	₹249 Cr
EBITDA	₹206 Cr	₹211 Cr	₹222 Cr	₹209 Cr	₹183 Cr	₹174 Cr	₹189 Cr	₹176 Cr	₹110 Cr	₹134 Cr	₹143 Cr	₹130 Cr	₹85 Cr	₹110 Cr	₹128 Cr	₹109 Cr	₹87 Cr	₹110 Cr	₹132 Cr	₹118 Cr	₹85 Cr	₹100 Cr	₹116 Cr	₹95 Cr	₹62 Cr
Net Profit	₹282 Cr	₹100 Cr	₹120 Cr	₹118 Cr	₹94 Cr	₹84 Cr	₹92 Cr	₹83 Cr	₹71 Cr	₹103 Cr	₹123 Cr	₹95 Cr	₹65 Cr	₹102 Cr	₹120 Cr	₹95 Cr	₹80 Cr	₹101 Cr	₹118 Cr	₹107 Cr	₹68 Cr	₹90 Cr	₹108 Cr	₹89 Cr	₹56 Cr
EPS	20.57	7.31	8.81	8.64	6.89	6.15	6.72	6.1	5.21	7.54	9.06	6.97	4.79	7.49	8.84	6.95	5.91	7.41	8.71	7.86	5.03	6.63	7.93	6.55	4.13

Profit & Loss (Annual)

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue	₹2,912 Cr	₹2,033 Cr	₹1,696 Cr	₹1,373 Cr	₹1,221 Cr	₹1,089 Cr
EBITDA	₹720 Cr	₹516 Cr	₹431 Cr	₹446 Cr	₹396 Cr	₹334 Cr
Net Profit	₹352 Cr	₹392 Cr	₹382 Cr	₹406 Cr	₹355 Cr	₹296 Cr
EPS	25.81	28.79	28.07	29.88	26.14	21.59

Balance Sheet

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Total Assets	₹7,033 Cr	₹7,040 Cr	₹3,667 Cr	₹2,272 Cr	₹1,835 Cr	₹1,552 Cr
Total Liabilities	₹3,761 Cr	₹3,818 Cr	₹1,447 Cr	₹364 Cr	₹258 Cr	₹256 Cr
Equity	₹3,272 Cr	₹3,222 Cr	₹2,221 Cr	₹1,908 Cr	₹1,576 Cr	₹1,296 Cr
Total Debt	₹1,738 Cr	₹655 Cr	₹644 Cr	₹45 Cr	₹0 Cr	₹0 Cr

Cash Flow

Metric	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating	₹1,163 Cr	₹587 Cr	₹369 Cr	₹462 Cr	₹444 Cr	₹323 Cr
Investing	₹-80 Cr	₹-1,855 Cr	₹-982 Cr	₹-320 Cr	₹-323 Cr	₹123 Cr
Financing	₹-881 Cr	₹1,380 Cr	₹688 Cr	₹-45 Cr	₹-82 Cr	₹-335 Cr
Free Cash Flow	₹1,163 Cr	₹587 Cr	₹369 Cr	₹462 Cr	₹444 Cr	₹323 Cr

Shareholding

Promoter 53.92% Institutions 26.75% Public 19.33%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search